Homeopathic Travel Vaccines

Featured

Originally published in Fitness Goop

Many people in the alternative health world are now seeking out alternatives to conventional vaccines. Homeopathy offers a safe, effective alternative to conventional vaccination. Homeopathic vaccines have been used for hundreds of years to prevent epidemic disease, and a number of studies prove their effectiveness.

Cuba Uses Homeopathic Vaccines to Protect 2.3 million people from Leptospirosis

In 2007, a homeopathic vaccine was administered to 2.3 million people in 3 provinces of Cuba to protect against Leptospirosis. A significant decrease in disease incidence was observed in the intervention region, whereas no such decrease in disease incidence was noticed in non-intervention regions (regions where homeopathic vaccines were not given for Leptospirosis). In the intervention region the incidence of Leptospirosis fell below the historic median. The homeopathic vaccination approach was associated with a large reduction of disease incidence and control of the epidemic.

Homeopathic Cholera Vaccines

In 1831 Samuel Hahnemann prevented and treated cholera during the 1831 Asiatic cholera epidemic with the remedies Camphor, Cuprum metallicum and Veratrum album. In 1849 Dr Clemens von Boenninghausen treated and prevented untold numbers of cholera infections during the 1949 European epidemic with the above remedies recommended by Hahnemann. While a death rate of 54-90% occurred with conventional treatment, Boenninghausen’s patients had a mortality rate of only 5-16%.

Homeopathic Polio Vaccines

In 1850 during an epidemic of poliomyelitis, Dr Taylor Smith of Johannesburg, South Africa protected 82 people with homoeopathic Lathyrus sativus. Of the 82 so immunised, 12 came into direct contact with disease. None were infected. Dr Grimmer of Chicago prophylactically treated 5,000 young children with Lathyrus sativus. None developed polio.

In 1957 a severe poliomyelitis epidemic occurred in Buenos Aires. The majority of homoeopathic doctors prescribed Lathyrus sativus as a preventative. Drug stores distributed thousands of doses to the public. None of those who used the prophylactic registered a case of contagion (Eizayaga). In 1975 during another poliomyelitis epidemic in Buenos Aires, 40,000 were given the homeopathic prophylactic Lathyrus sativus. None developed poliomyelitis (Eizayaga).

Homeopathic Japanese B Encephalitis Vaccines

In 1999 the Department of Indian Medicine and Homeopathy started distribution of homeopathic vaccines for Japanese Encephalitis in a systematic way throughout the Indian state of Andrha Pradesh. JE mortality rates had touched a high of 638 deaths from 2038 cases in 1986, but fell to four from 33 cases in 2001, following the implementation of the homeopathic immunization program. Even the World Health Organisation and the Medical and Health Department acknowledge that homeopathic vaccines have been a vital factor in the sharp decline of Japanese Encephalitis cases in Andrha Pradesh.

A study published in 2010 by researchers at Kolkata’s School of Tropical Medicine and the Central Council for Research in Homeopathy showed that the homeopathic medicine Belladonna prevented infection in chick embryos infected with the Japanese Encephalitis virus.

The study showed significant decrease in the viral load when treated with the homeopathic medicine Belladonna in different potencies, in comparison to placebo, said principal investigator Dr. Bhaswati Bandopadhyay, assistant professor of virology, School of Tropical Medicine.

Homeopathic Diptheria Vaccines

A laboratory experiment in 1932 published by Dr Chavanon showed that 45 children became Schick test negative (indicating the presence of antibodies to diphtheria) after being treated with Diphtherinum. The test was repeated by Drs Patterson and Boyd with 23 out of 33 children becoming Schick test negative after being given Diphtherinum. In 1947 Dr Roux repeated the test and produced a similar result (Eizayaga).

Learn more about homeopathic vaccines:http://www.littlemountainhomeopathy.com/vaccine-alternatives

References

Bandyopadhyay, Bhaswati et al. “Decreased Intensity of Japanese Encephalitis Virus Infection in Chick Chorioallantoic Membrane Under Influence of Ultradiluted Belladonna Extract,” American Journal of Infectious Diseases, Diseases 6 (2): 24-28, 2010

Bracho G, Varela E, Fernandez R, et al. “Large-scale application of highly-diluted bacteria for Leptospirosis epidemic control.” Homeopathy 2010; 99: 156-166.

Chavanon, P. 1952. La Dipterie, 4th Ed, St Denis, Niort: Imprimerie.

Eisfelder, HW, “Poliomyelitis Immunization: A Final Report.” Journal of the American Institute of Homeopathy. V. 54, Nov-Dec 1961, pp. 166-167.

Eizayaga. F. “Tratamiento Homeopatico de las Enfermedades Agudas y Su Prevension.” Homeopatia. 1985; 51(324): pp. 352-362.

Eizayaga, Dr. F. X., Treatise on Homeopathic Medicine. (E. Marecel, Buenos Aires, pp. 282-286).

Hahnemann, Dr. Samuel. “Cause and Prevention of the Asiatic Cholera.”Archiv. f. hom. Helik., vol. xi, 1831.

Patterson, J. and Boyd, W.E. “Potency Action: A Preliminary Study of the Alternation of the Schick Test by a Homeopathic Potency.” British Homeopathic Journal. 1941; 31: pp.301-309.

Staff Reporter. “Japanese Encephalitis on the Decline in State,” The Hindu, April 1, 2003.

Taylor-Smith, A. “Poliomyelitis and prophylaxis.” Br Homeopath J, 1950 Apr;40(2):65-77.

By Sonya McLeod
Google Plus Author Profile Page

Homoeopathic Immunisation Against Leptospirosis in Cuba

Featured

by Dr. Isaac Golden and Dr. Gustavo Bracho

Originally published in Hpathy.com

Hahnemann first used a homoeopathic potency of Belladonna, selected using the Law of Similars, to prevent Scarlet Fever in 1798. Since then homoeopathic immunisation, or homoeoprophylaxis, has been used by tens of thousands of homoeopaths. Results have been described in our literature, but there has been relatively little formal statistical analysis of results. Further, most interventions have been by individual practitioners with relatively few people. This paper provides a graphical description of the use of homoeoprophylaxis by a government’s medical institute to protect literally millions of people. This experience has the potential to change the way homoeoprophylaxis is viewed by parents, practitioners and governments around the world.

Introduction:

The use of homoeoprophylaxis (HP), or homoeopathic immunisation, has been debated in this journal. Some homoeopaths oppose it on philosophical grounds (see the debate between Professor Vithoulkas and Dr Golden), some on more technical/political grounds (see the views of Dr Fisher which have been contested by Dr Golden). However HP has considerable support internationally being, as it is, part of Hahnemann’s “classical” method based squarely on the Law of Similars, and first used by him in 1798.

Irrespective of conceptual issues, the principal question is whether HP is effective and safe. Both aspects have been thoroughly researched and the evidence published. The question of safety is relatively easy given the absence of toxic materials in potentised remedies; however the question of effectiveness and efficacy remains hotly contested by orthodox scientists. They say that homoeopathy in general is “implausible” because “nothing is there” and therefore both treatment and prevention cannot work irrespective of the evidence. Whilst this is a very unscientific response, it remains the responsibility of advocates of HP to show convincing evidence that it does work.

Due to the recent massive HP interventions in Cuba, we can now offer four main types of evidence to support the effectiveness of both short-term and long-term HP, being:

  1. The historical use of HP from Hahnemann in 1798 to the present day, widely evidenced throughout the homoeopathic literature, and used by many “masters” of homoeopathy
  2. Short-term use of HP in epidemic situations. One of the most thorough of such studies has been by Morinski and colleagues in 1998. A review of such research points to an effectiveness of around 90%.
  3. Long-term use of HP in non-epidemic situations. Golden showed an effectiveness of 90.4% in his research from 1986 to 2004.
  4. The massive and highly successful HP interventions in Cuba involving millions of people from 2007 to 2010.

It is this latter piece of evidence that we will now examine further.

Leptospirosis in Cuba

Leptospirosis is a zoonotic disease which is endemic in Cuba. It usually worsens during the hurricane and high rainfall seasons from October to December each year when the infection is spread via infected water, although rodent urine will also carry the disease.

The three eastern regions of Cuba, Las Tunas, Holguin and Granma (IR = Intervened Region) usually have a much greater incidence of the disease per head of population than the rest of the country (RC) as is clear from Figure 1 which shows the average weekly incidence of leptospirosis for 2003-2006 in IR (2.4 million people) and RC (8.8 million people), weighted per head of population figure for both regions (Average x population in Cuba/population in region).

Figure 1: Leptospirosis, IR and RC, 2003-2006 weekly average weighted per head of population


In both 2007 and 2008 the RC was hit by severe hurricanes. In 2007 the Cuban Government, through the Finlay Institute which manufactures most vaccines used in Cuba, decided to homeopathically immunise the bulk of the population in IR due to a severe spike in the incidence of the disease.

Figure 2 shows the Incidence of the disease in 2007, and the impact of the two-dose HP program which was conducted in Week 45. Once again a weighted per head of population figure is shown, which illustrates the impact of the intervention even more clearly.

2007 was already a worse than average year for residents of IR, and became dramatically so following the hurricanes. However the outbreak “broke” in IR in Week 47, 2 weeks following the HP intervention, although it continued in RC where there was no intervention.

Figure 2: Leptospirosis in IR and RC, 2007, weekly, weighted per head of population


A second two-dose round of HP was administered in 2008 to the residents of IR, this time using a higher potency of the remedy (200C in 2007, 10,000C in 2008 – 2 doses a week apart). Figure 3 shows that the disease remained contained in IR (once again, the most at risk region), but continued as expected in RC apart from a significant single incident in Week 42.

Figure 3: Leptospirosis in IR and RC, 2008, weekly, weighted per head of population


The impact of the HP intervention is clear from the above Figures, but was also demonstrated when comparing the actual progression of the disease in IR in 2007 with the expected number of cases derived using a predictive model based on rainfall experience over time, plus other factors. Figure 4 has been reproduced in other studies of the intervention,,.

Figure 4: Leptospirosis in 2007, actual and predicted incidence


One issue regarding this diagram was the reliability of the predictive model used. Further examination revealed that the model used was quite reliable in IR, but less so in RC.

One final examination of the leptospirosis data from 2004 to 2008 is presented in Figure 5, showing the incidence of the disease for both regions. It shows clearly the seasonal peaks and troughs over the years, with a breaking of the seasonal trend in IR in late 2007, and the substantial reduction of the disease in IR in 2008 despite IR remaining the region most at risk due to severe hurricanes in IR in 2008. It also shows the 2007 prediction for IR shown in Figure 4 (without the HP intervention factored in), but this time shown in monthly figures rather than weekly as in Figure 4.

At this time a predictive trend for 2008 excluding the influence of the HP interventions is not available, but it certainly would show a higher incidence of the disease than that which occurred in RC. However the data which is available clearly shows the positive impact of the interventions. (See Fig. 5 below)

Figure 5: Leptospirosis cases in IR and RC from 2004 to 2008


Concluding Comments

The HP intervention against leptospirosis in IR in 2007 and 2008 has been an unqualified success. The details of the effective intervention were mentioned in the Cuban Assembly. Following on this experience a decision was made to undertake a massive HP immunisation of the total population against Swine Flu in 2009/10 involving over 9.8 million people. The results of this intervention will not be known until 2011 when data can be assembled and analysed.

It is clear that the Cuban initiative in safe, effective, and low cost infectious disease prevention, making the Cubans world leaders in this area of immunisation, will be followed with great interest by both practitioners and public health scientists around the world.

i. George Vithoulkas and Isaac Golden, in hpathy.com, April – September, 2007.
ii. As evidenced in the debate between Dr Fisher and Ben Goldacre. Natural History Museum. http://www.nhm.ac.uk/nature-online/nature-live/video-archive/videos/homeopathic-medicine/
iii. Golden I. A Respectful Challenge to Dr Peter Fisher Regarding Vaccination. J. Hom Med Assn. May, 2009.
iv. Hahnemann S. The Cure and Prevention of Scarlet Fever. Lesser Writings. B.Jain Publishers.
v. Golden I Vaccination & Homoeoprophylaxis? A Review of Risks and Alternatives. 7th edition 2010. Isaac Golden Publications, Cherokee, Victoria, Australia.
vi. For a summary of some major references see Golden I, Homoeoprophylaxis, A Practical and Philosophical Review. Isaac Golden Publications, Cherokee, Victoria, Australia.
vii. Mroninski C, Adriano E, Mattos G. Meningococcinum: Its protective effect against meningococcal disease. Homoeopathic Links Winter, 2001. Vol 14(4); pp. 230-4.
viii.Golden I. Homoeoprophylaxis: A Fifteen year Clinical Study. Isaac Golden Publications, Cherokee, Victoria, Australia. 2004.
ix. Campa C, Bracho G, Cruz R, Menendez J, Martinez R, Gilling E, Wella R. Homoeoprophylaxis: Cuban Experiences on Leptospirosis. Nosodes 2008, International Meeting on Homoeoprophylaxis, Homoeopathic Immunisation and Nosodes Against Epidemics. Havana, Cuba. 10-12h December, 2008.
x. Bracho G, Varela E, Fernández R, Ordaz B, Marzoa N, Menéndez J, García L, Gilling E, Leyva R,Rufín R, de la Torre R, Solis R, Batista N, Borrero R ,Campa C. Massive Application of Highly Diluted Bacteria as Homeoprophylactic Formulation for Leptospirosis Epidemic Control. Homeopathy. 2010. 99, 156-166.
xi. Golden I, Bracho G. The Homoeopathic Prevention of Leptospirosis in Cuba. J.Am. Institute of Homeopathy. Summer. 2010.

Dr Isaac Golden is Business Manager Academic Operations at Endeavour College of Natural Health. He has been in homeopathic practice since 1984, and has conducted the world’s largest long-term trial of homoeoprophylaxis, which formed the basis for his Doctorate in 2004, the first time a mainstream Australian University awarded a PhD in a homeopathic topic. He has authored 10 books on homoeopathy and many articles in Australia and internationally.

Dr Gustavo Bracho is Advisor to the President and General Director of Finlay Institute, Havana, Cuba, and head of the Homeopathy and Biotherapic Projects at the Institute. He is an experienced researcher in molecular and cellular biology, and has headed the Adjuvant Group within the Immunology Department of Finlay. In 2005-2006 he was a researcher in a Collaboration Project with the Flinders Medical Centre, Adelaide, Australia, examining vaccine production methods. He has pioneered the use of homoeoprophylaxis in Cuba as both an adjunct to or an alternative for orthodox vaccination. He is widely published in his area.

Chickenpox Parties Need to Make a Comeback

Featured

I remember getting chickenpox as a child in the early ’80s. Due to the highly infectious nature of chickenpox, all the kids in the neighbourhood got it. None of our parents blinked an eyelash because they knew that chickenpox was a harmless disease if acquired during childhood with a very low risk of complications.

Before the introduction of the chickenpox vaccine in 1999 here in Canada, it was fairly common for parents to hold “chickenpox parties.” A chickenpox party involves the deliberate exposure of children infected with the chickenpox virus to other children who have not yet been exposed to the disease. Parents willingly expose their children to the disease in order to grant their children life-long immunity to chickenpox. These “chickenpox party” parents know that chickenpox is a mild disease if acquired during childhood, but infection is riskier when acquired by teens or adults.

What Changed?

Before the introduction of the vaccine, chickenpox (varicella) was considered by almost everyone to be a mild disease, and parents were not concerned if their children were infected with it. Now, most parents are horrified by the idea of chickenpox parties. So what’s changed?

Relatively Benign Disease in Childhood Becomes Risky in Adulthood

In general, complications as well as fatalities from chickenpox are more commonly observed in adults than in children. Case-fatality ratios (deaths per 100 000 cases) in healthy adults are 30-40 times higher than among children aged 5-9 (WHO). Each year from 1990 to 1994, prior to the availability of varicella vaccine, about 4 million cases of chickenpox occurred in the United States. Of these cases approximately 10,000 required hospitalization and 100 died. After the introduction of the vaccine in 1995, overall US chickenpox deaths plummeted to 66 per year in 2001 and hospitalizations declined significantly. However, death rates from chickenpox did not decline for those aged 50 or older (NEJM).

A Decrease in Chickenpox Infection Leads to an Increase in Shingles

Shingles (herpes zoster) is a debilitating, painful skin rash acquired in adulthood. After a child has been exposed to the chickenpox virus, the virus remains latent in the body. The varicella virus can later be reactivated as shingles later in life. If the varicella virus infects the nerve cells, it can cause an extremely painful condition called postherpetic neuralgia. Nerve pain caused by postherpetic neuralgia can last for months and in some cases even years. Approximately 200,000 adult Americans are afflicted with postherpetic neuralgia every year.

There is  scientific evidence that adults who are regularly exposed to children infected with the chickenpox virus have increased protection against the shingles (Thomas). Thus, natural exposure to the chickenpox virus boosts adults’ immunity against shingles, acting like a natural shingles vaccine. Since chickenpox infection rates are now so low in Canada and the US, chances of adult exposure to the virus is also low, thus scientists expect an eventual shingles epidemic to emerge in the coming years (Brisson).

Since the beginning of the mass chickenpox vaccination campaign in the US, deaths and hospitalizations did decrease, but studies also showed that shingles increased over that same time period (Yih; Mullooly). A recent MacLeans article quotes several scientists who admit that more varicella vaccine coverage has already sparked an increase in shingles in Canada and the US, plus it is shifting shingles incidence to a younger population.

Introducing the Shingles Vaccine

Merck, the manufacturer of the varicella vaccine, is forcing a shingles epidemic on the American (and Canadian) population. But they cleverly “fixed” the problem that they created when they invented a vaccine for shingles in 2007. Now they are trying to push the shingles vaccine on the elderly population of North America.

What Next?

The chickenpox vaccine is  decreasing the incidence of a mild disease, and in exchange is increasing the incidence of a more debilitating disease: shingles. Now what? Once the entire elderly population starts vaccinating against shingles, what new problem will that create?

Time to Bring Back Pox Parties

Big Pharma companies like Merck have profits, not your health, in mind. It’s time to take your family’s health into your own hands. Have a pox party. Build your child’s immunity naturally instead of relying on vaccines. Adults should attend these parties as well because natural exposure to the chickenpox virus boosts their immunity to shingles.

Organize a Chickenpox Party in Vancouver

Join this yahoo group to find other like-minded parents to organize pox parties with: http://health.groups.yahoo.com/group/chickenpoxinvancouverbc/

Still concerned about the chickenpox? Read about a safe, effective alternative to vaccinations: Homeopathic Immunizations

Enjoy this article? You might enjoy this one as well: Fear the MMR Vaccine, Not the Measles

References

Belluz, Julia. “Why are ever-younger adults contracting shingles? No longer just a disease of the elderly.” MacLeans. August 16, 2010.

Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002 Jun 7;20(19-20):2500-7.

Health Protection Agency. “Latest HPA modelling reveals chickenpox vaccination would lead to more shingles among elderly despite introduction of shingles vaccination” September 17, 2008.

Mullooly JP, Riedlinger K, Chun C, et al. Incidence of herpes zoster, 1997–2002.Epidemiol Infect 2005;133:245–53.

Pollack, Andrew “Chickenpox Vaccine Cuts Deaths but Raises Question on Shingles.” New York Times, February 3, 2005.

Thomas SL, Wheeler JG, Hall AJ. “Contacts with varicella or with children and protection against herpes zoster in adults: a case controlled study” Lancet. 2002 Aug 31;360(9334):678-82.

Yih WK, Brooks DR, Lett SM, et al. “The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage,” 1998–2003. BMC Public Health2005;5:68.

By Sonya McLeod
Google Plus Author Profile Page

Fear the MMR Vaccine, Not the Measles

Featured

The Propaganda

At the end of March 2010 the mainstream media loudly announces an outbreak of measles in BC. As of April 16 there have been 44 cases of measles reportedaround the Vancouver Lower Mainland, the BC Interior and Northern BC. No serious complications have been reported thus far though the media is using its usual scare tactics to urge the unvaccinated population to run out to get the MMR vaccine. Some schools are actually sending unvaccinated children home because they feel that measles is such a serious threat.

Simple Solution
Poverty and Malnutrition  are the Problem, Not the Measles

The press gives the impression that measles can only be kept under control by vaccination, but there is another side to the story. According to figures published in International Mortality Statistics, from 1915 to 1958 the measles death rate in the U.S. and U.K. declined by 98% (Miller). A chart illustrating the decline was published in a Public Health Report: “Mortality in the United States, 1900-1950.” The measles vaccine was introduced a few years after the decline, in 1963. The decline was not due to the vaccine, so most likely it was due to better sanitation, nutrition, and standards of living in the U.S. and U.K. Today, measles is a mild disease in first world countries but can be more severe in third world countries and in impoverished populations in the first world (Fisher). According to several studies, Vitamin A deficiency plays a big role in complication rates and chances of dying from measles (Sommer; Barclay; Keusch; Frieden). A simple solution to the measles problem is to improve hygiene and nutrition in impoverished populations.

Questionable Statistics

The Centers for Disease Control and Prevention (CDC) estimates the rate of measles-induced encephalitis at 1 in every 1000 infected. Dr. Robert Mendelsohn, renowned pediatrician and vaccine researcher, questions the CDC’s numbers. He says those numbers may be accurate for people living in impoverished conditions, but for those with adequate nutrition and living conditions, the true incidence of measles-induced encephalitis is more like 1 in 10,000 or 1 in 100,000. In his bestselling book The Vaccine Guide, homeopathic pediatrician Dr. Neustaedter asserts that only 25 percent of measles induced encephalitis cases show evidence of brain damage.

Vaccine Failure

Vaccine manufacturers would like you to believe that the MMR vaccine is 100% effective, but this is not always the case. In 1988, the CDC reports that in the U.S. a whopping 45% of those who contracted the measles were fully vaccinated. The next year, in 1989 in the U.S., the CDC reports that a surprising 40% of those who got the measles were fully vaccinated. In 1996 in the U.S., the CDC reports that only 64% of those who got the measles were unvaccinated and the rest were fully vaccinated. Studies done in Ethiopia and India reported varying vaccine efficacy rates of between 53%-100% (Talley; Puri). Dr. Neustaedter estimates that approximately 60% of all children infected with the measles will have been previously vaccinated. Measles outbreaks have been reported in schools where the entire school population was fully vaccinated (Gustafson; Poland; Edmonson). Edmonson concludes that as measles immunization rates rise to high levels in a population, measles becomes a disease of immunized persons.

Vaccination Shifts Infection Risk to More Vulnerable Populations

The measles vaccine alters distribution of the disease by shifting incidence rates from age-groups unlikely to experience problems (children aged 5-9) to age-groups most likely to suffer from severe complications (infants, teenagers, and adults). According to the National Foundation for Infectious Diseases, the risk of death from measles is higher for infants and adults than for children. Before the vaccine was introduced it was rare for an infant to contract measles, but by the 1990s more than 25% of all measles cases were occurring in babies under a year of age (Miller). This can be attributed to the growing number of mothers who were vaccinated in the 60s, 70s, and 80s (Haney). Before the vaccine, mothers were able to pass protective maternal antibodies to their babies, but now babies of vaccinated mothers are more vulnerable to measles (Papania). Before the introduction of the vaccine, measles was acquired in childhood before reaching adulthood. Now, since the introduction of the vaccine, measles incidence in the adult population in Canada and the U.S. is steadily increasing (Duclos).

Studies Suggest a Link Between MMR Vaccine and
Autism, Irritable Bowel Syndrome and Ulcerative Colitis

There are studies that link the MMR vaccine with some serious health disorders. One study links MMR vaccination with irritable bowel syndrome (Thompson). Scientific papers have been published reporting a likely link between the MMR vaccine and autism (Taranger; Rutter). These studies done by Taranger and Rutter linked the onset of the studied children’s autism with immunization. A controversial scientific paper by Andrew Wakefield published in the Lancet also states that the parents of the autistic children linked the onset of symptoms with the administration of the MMR vaccine. Another study has been done that confirms Wakefield’s findings (O’Leary). In 2000, a study was done confirming the existence of the vaccine strain of the measles virus in the guts of patients with autism and ulcerative colitis (Kawashima). Two studies done by Singh et al.  in 2002 and 2003 confirmed the presence of MMR antibodies in autistic children, again suggesting a link between the MMR vaccine and autism. Singh concludes that the autistic children he studied had a hyper immune response to the vaccine strain of the measles in the MMR vaccine. In a paper published in 2004,  measles virus was found in the spinal fluid of the autistic children studied and the authors conclude that it was very likely the vaccine strain of the virus (Bradstreet). Geier & Geier were able to measure a correlation between mercury doses from thimerosal- containing vaccines and the prevalence of autism in the 1980s and 90s. Although thimerosal has now been removed from the MMR vaccine in Canada, Geier & Geier were also able to find some correlation between measles-containing vaccines and the prevalence of autism in the 1980s.

MMR Vaccine Banned in Japan

The MMR vaccine was banned in Japan in 1993. Soon after introducing the vaccine, a record number of children developed non-viral meningitis and and other adverse reactions. An analysis of vaccinations over a three-month period showed one in every 900 children was experiencing problems. This was over 2,000 times higher than the expected rate of one child in every 100,000 to 200,000.

Although measles is a mild disease in healthy children, safe protection can be offered to those who would like it. To learn more about homeopathic immunizations, read my blog post – Homeopathic Immunizations: A Proven Alternative to Vaccinations and you are also welcome to visit the Homeopathic Immunizations section of my website. Feel free to contact me with any questions you may have about homeopathic immunizations.
References

Barclay, A.J.G., et al. “Vitamin A supplements and mortality related to measles: a randomised clinical trial.” British Medical Journal (January 31, 1987) pp. 294-96.
Bradstreet, J.J., et al. “Detection of measles virus genomic RNA in cerebrospinal fluid of children with regressive autism: a report of three cases.” J Am Phys Surg. 2004:9(2):38-45.

Duclos, P., et al. “Measles in adults in Canada and the United States: implications for measles elimination and eradication.” Int J Epidemiol. 1999 Feb;28(1):141-6.

Edmonson, M. B., et al. (1990). “Mild Measles and Secondary Vaccine Failure During a Sustained Outbreak in a Highly Vaccinated Population.” JAMA
263: 2467-2471
Fisher, B.L., The Consumer’s Guide to Childhood Vaccines (Vienna, VA: National Vaccine Information Center, 1997), p. 18.
Frieden, T.R., et al. “Vitamin A levels and severity of measles: New York City.” Am J Dis Child 1992; 146: 182-86

Geier M.R., and Geier D.A. “A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism..” Med Sci Monit. 2004 Mar;10(3):PI33-9. Epub 2004 Mar 1.
Gustafson, T.L., “Measles Outbreak in a Fully Immunized School Population.” N Engl J Med 1987;316:771-4.
Haney, Daniel Q., “Wave of Infant Measles Stems from ’60s Vaccinations,” Albuquerque Journal, (November 23, 1992), p. B3
Kawashima, T., et al. “Detection and Sequencing of Measles Virus from Peripheral Mononuclear Cells from Patients with Inflammatory Bowel Disease and Autism” Dig Dis Sci. 2000 Apr;45(4):723-9.
Keusch, G.T. “Vitamin A supplements–too good to not be true.” New England Journal of Medicine (October 4, 1990), p. 986.

Mendelsohn, Robert. How to Raise a Healthy Child . . . In Spite of Your Doctor (Ballantine Books, 1984), pp. 231 and 251.
Miller, Neil Z., Vaccines: Are They Really Safe and Effective? New Atlantean Press, 2002.
Neustaedter, R. The Vaccine Guide. (Berkeley, CA: North Atlantic Books, 1996), pp.107-108.
O’Leary JJ, et al. Measles virus and autism. Lancet. 2000 Aug 26;356(9231):772.
Papania, Mark et al., “Increased Susceptibility to Measles in Infants in the United States.” Pediatrics Vol. 104 No. 5 November 1999, p. e59
Poland, G. A., Jacobson, R. M. (1994). “Failure to Reach the Goal of Measles Elimination: Apparent Paradox of Measles Infections in Immunized Persons.” Arch Intern Med 154: 1815-1820
Puri, A. et al. “Measles Vaccine Efficacy Evaluated by Case Reference Technique.” Indian Pediatr. 2002 Jun;39(6):556-60.s,
Roberts, R.J. et al. “Reasons for non-uptake of measles, mumps and rubella catch up immunisation in a measles epidemic and side effects of the vaccine.” BMJ 1995;310:1629-1639 (24 June)
Rutter, M. et al. “Autism and known medical conditions: myth and substance.” Journal of Child Psychology and Psychiatry. 1994;35:311-322.
Singh, V.K., et al. “Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in Children with Autism.” J Biomed Sci. 2002 Jul-Aug;9(4):359-64.
Singh, V.K., Jensen R.L. “Elevated levels of measles antibodies in children with autism.” Pediatr Neurol. 2003 Apr;28(4):292-4.
Sommer, A., et al. “Increased risk of respiratory disease and diarrhea in children with pre-existing mild vitamin A deficiency.” American Journal of Clinical Nutrition 1984; 40: 1090-1095.

Sommer, A., et al. “Impact of vitamin A supplementation on childhood mortality: a randomized controlled community trial.” Lancet 1986; 1:1169-73.

Talley, L. and P. Salama. “Short report: assessing field efficacy for measles in famine-affected rural Ethiopia. Am J Trop Med Hyg. 2003 May;68(5):545-6.
Taranger J, Wiholm BE. Litet antal biverkninger rapporterade efter vaccination mot massling-passguka-roda hund. Lakartidningen. 1987;84:958-950.
Thompson, N.P. Wakefield et al. “Is measles vaccination a risk factor for inflammatory bowel disease?” Lancet 1995; 345: 1071-1074.
Wakefield et al. “Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.” Lancet. 1998 Feb 28;351(9103):637-41.

Wave of Infant Measles Stems From ’60s Vaccinations

By Sonya McLeod
Google Plus Author Profile Page

Homeopathic Immunizations: A Proven Alternative to Vaccinations

Featured

Homeoprophylaxis – A Proven Alternative to Vaccination

By Dr Isaac Golden

I prepared my first formal program of homeopathic remedies to prevent infectious diseases in 1986. In the following 20+ years, tens of thousands of Australian children have been immunized homeopathically – a method called homeoprophylaxis (HP) – using programs from myself as well as other practitioners across the country. The method itself is over 200 years old, and has considerable clinical and research experience to support its claims.

In 2004, I integrated 18 years of data collection from parents of children using my program with 4 years of doctoral research at Swinburne University in Melbourne. The purpose of this article is to share with you the findings of this and other research into the effectiveness and safety of HP.

Background

The use of HP was first described by Dr Samuel Hahnemann, the founder of homeopathy, in 1801. He used the remedy Belladonna 30 to successfully treat patients with the disease Scarlet Fever, but fortuitously found that the remedy also helped to prevent the disease. He then used HP to prevent such diseases as Cholera and Typhoid. In the decades following, many leading homeopaths used HP to prevent a variety of infectious diseases, mainly in acute epidemic situations.

The largest trial of the short-term use of HP was against an outbreak of Meningococcal disease in Brazil. The researchers gave 65,826 children the homeopathic remedy Meningococcinum. Another 23,539 were not protected. The effectiveness of HP after 6 months was 95%, and after a 12 months follow-up was 91%.

Whilst many homeopaths also use HP for long-term prevention (mainly in Australia and the Indian subcontinent), there had been very little formal statistical research into the long-term use of HP prior to 1985. The data I have collected since that time provides a useful guide as to the effectiveness and safety of long-term HP. It confirms that the findings regarding epidemic use also extend to long-term use, with an average effectiveness of around 90%, and a very high level of safety. These findings are presented below.

The Effectiveness of Homeoprophylaxis

As mentioned above, we have a considerable amount of clinical evidence showing that HP provides a high level of protection against targeted infectious diseases. This is supported by a small number of statistical trials which are summarized in Table 1 below. These show an average effectiveness of around 90%, which certainly is comparable to measures of vaccine effectiveness, which range from 70% to 99%, depending on the individual vaccine, and the type of trial used to measure efficacy (real-world experiences show lower rates than clinical trials).

These figures confirm that no method of disease prevention is ever 100% effective.

No statistical study is ever perfect, and of course the reliability of my data is open to question. So as part of my Swinburne research, I applied seven statistical tests to validate the long-term data I have been collecting since 1985. These are described in detail elsewhere, and they did show a high level of reliability. For example, my single figure measure of long-term HP effectiveness was 90.4%, with 95% confidence limits of 87.6% – 93.2% (i.e. it can be stated with 95% confidence that the efficacy lies between 87.6% AND 93.2%), a very strong result.

Table 1: The Effectiveness of HP – Statistical Trials in Humans

Year Researcher* Numbers of Participants Length of Survey Effectiveness %
1907 Eaton 2,806 < 1 year 97.5
1950 Taylor-Smith 82 (12 definitely exposed) < 1 year 100.0
1963 Gutman 385 < 1 year 86.0
1974 Castro &Nogeira HP 18,000
Not HP 6,340
3 months 86.1
1987 English 694 2 years 87.0 – 91.5
1987 Fox 61 5 years 82.0 – 95.0
1998 Mroninski et al HP 65,826
Not HP 23,539
6 months
12 months
95.0 – 91.0
1997 Golden 593 children1,305 questionnaires 10 years 88.8
2004 Golden 1,159 children
2,342 questionnaires
15 years 90.4

* References for these studies may be found in Vaccination and Homeoprophylaxis – A Review of Risks and Alternatives, 6th edition

So those in pharmaceutical medicine who state that there is no evidence supporting the effectiveness of HP are clearly wrong. It is not essential to rely only on randomized clinical trials (RCTs) to provide evidence, and in fact the findings of many RCTs are shown to be questionable over time (e.g. drugs such as Vioxx that were tested in RCTs, then later withdrawn from use because of side-effects not discovered or acknowledged during the RCTs).

Thus homeopaths can confidently say that HP provides a definite level of protection against targeted infectious diseases, which is not 100%, but which is comparable to that of vaccines.

The Safety of Homoeoprophylaxis

Homeopathic medicines are usually prepared using a series of dilutions and succussions (firm striking of the container holding the liquid remedy against a firm surface). The remedies are called “potencies” because at each stage they become energetically stronger. After the 12c potency, no molecules of the original substance remain, yet the remedy is energetically stronger. Pharmaceutical advocates cannot understand this, because their paradigm forces them to believe that as the number of molecules of a substance decreases in a medicine, the medicine becomes weaker. This is true if the kinetic energy of the succussion is not correctly applied, and a simple dilution only is prepared. But we are making much more than a simple dilution.

Doctors agree that homoeopathic potencies cannot be toxic, and so physical safety is not an issue. However, some homeopaths have expressed concerns over the years as to whether the long-term use of the remedies in my HP program is energetically safe. Many people who are not bound to the pharmaceutical paradigm understand that energy can produce real and tangible effects, and if misused can cause problems. One important part of my research at Swinburne was to check the long-term safety of HP.

This was done by examining 5 markers of overall wellbeing in children aged between 4 and 12 years of age – asthma, eczema, ear/hearing problems, allergies and behavioural problems. These were compared to a range of early childhood markers, including breastfeeding status, birthweight, APGAR scores, as well as to 4 possible immunization methods – vaccination, HP, general/constitutional prevention, and no prevention at all. That gave 20 (5 x 4) possible combinations of health conditions and immunization methods. The data was processed using Odds Ratios and Chi Squared Probability tests.

Once again, the full results are reported in detail elsewhere, but the main findings are as follows:

  1. In 19 of the 20 possible measures of health, vaccinated children were less healthy than other children, usually by a significant amount (the 1 measure favouring vaccination was not statistically significant). The most dramatic single finding was that vaccinated children have a 15 times greater chance of becoming asthmatic than children using HP, with P>99%, a highly statistically significant finding.
  2. Children using HP were generally at least as healthy (and often more healthy) as children who used constitutional/general immunization or no immunization at all. The HP group were not exclusively from people who were extremely health conscious. Regularly, parents using my HP program say that it is their first introduction to homeopathy and to natural medicine in general.
  3. Parental estimates of general well-being were very high in the HP group – at least as high as in other groups.
  4. Not all HP programs give consistent results. When comparing children using my HP program to those using other HP programs, the levels of both effectiveness and safety were lower in the group using other programs. So it is advisable to check the basis of a HP program before committing to it. Programs using daily doses of low potencies provide less effective long-term prevention than programs using infrequent doses of (appropriately selected) high potencies.

We may conclude from the parts of my data which were statistically significant (P?95%), that HP is associated with an improvement in general health, compared to other immunization methods (as well as no immunization at all), and that this figure is significantly better when compared to vaccinated children. Therefore we may conclude that the evidence suggests that the use of an appropriate long-term HP program does not lessen the health of children, and evidence suggests that it may in fact assist the maturation of the immune system by gently challenging the system in the first 5-6 years of life.

Concluding Comments

What began as a limited study 20 years ago has grown, for me, into an ongoing attempt to make parents, as well as health professionals, aware of the wonderful opportunity that homoeoprophylaxis offers to provide protection against target infectious diseases, without risking the long-term health of their children. It may be safely used by adults.

Not every infectious disease is a dire threat to a healthy infant. I personally don’t believe that immunization against every infectious disease is essential. But I do believe that the right to choose which diseases should be prevented should belong to the parents of each child. We can confidently say to parents that they can provide a high (but not complete) level of protection against targeted diseases, without risk, by using an appropriate HP program.

We can also say to those within the pharmaceutical industry who disparage HP as being untested and uncertain – take the time to study the facts available. Criticism without facts is the antithesis of the true scientific method, yet it is the response we continually get from pharmaceutical medicine when it comes to HP.

I concluded my doctoral thesis by saying that “a national immunization system, where both vaccination and HP were available to parents, would increase the national coverage against targeted infectious diseases, and reduce the incidence of some chronic health conditions, especially asthma”. The data is unambiguous, and it is time that those who run the health services of this country get serious about long-term health, and fully support the use of the best of what natural medicine in general, and homeopathic medicine in particular, has to offer.

Vaccines offer a level of protection against targeted infectious diseases, but involve a long-term risk that has never been adequately measured. Evidence shows that vaccination is a factor in the increase in asthma (and other chronic diseases) shown earlier. We can achieve a comparable level of protection, without this risk, by using an appropriate long-term HP program. It’s time that those parents who search for facts to inform themselves before vaccinating are encouraged, and not attacked by agents of the pharmaceutical industry. It’s time that parents are supported in their choice of immunization method, for the benefit of their own children and of the entire community.

For a more thorough review of the history, statistics, science and research of Homeopathic Immunizations, visit the Little Mountain Homeopathy Homeopathic Immunizations Info Page

References

Golden I. Homoeoprophylaxis – A Fifteen Year Clinical Study. 2004. Isaac Golden Publications. Daylesford.

Golden I. Homœoprophylaxis – A Practical and Philosophical Review. 2001. Isaac Golden Publications, Daylesford, Australia. 3rd edition.

Golden I. The Potential Value of Homœoprophylaxis in the Prevention of Infectious Diseases, and the Maintenance of General Health in Recipients. 2005. Swinburne University Press, Melbourne.

Golden I. Vaccination – A Homoeopathic Perspective. Nature & Health. Vol 7. No.3. Sept 1986, pages 67-70.

Golden I. Vaccination and Homoeoprophylaxis – A Review of Risks and Alternatives, 6th edition. 2005. Isaac Golden Publications. Daylesford.

Hahnemann S. The Cure and Prevention of Scarlet Fever. 1801. Republished in Lesser Writings. B Jain Publishers, New Delhi; pp. 369-385.

Mroninski C, Adriano E, Mattos G. Meningococcinum: Its protective effect against meningococcal disease. Homoeopathic Links Winter, 2001. Vol 14(4); pp. 230-4.

National Health and Medical Research Council (NH&MRC). The Australian Immunisation Handbook, 8th Edition. 2003. Commonwealth of Australia, Canberra.

About the Author…

Dr Isaac Golden has been in homeopathic practice since 1984. He has written 8 books on homeopathic topics and currently consults in Gisborne, Victoria. Since 1990, he has been Principal of the A.C.H.H., a correspondence college teaching homeopathy and has recently been appointed as Adjunct Professor of Homeopathy at the Australian College of Natural Medicine. He is a world authority on the use of homeoprophylaxis, and has completed the world’s largest long term trial of the method. He was awarded a PhD from Swinburne University in 2004 as a result of the research on HP he has undertaken over the last 20 years. Click here for further information about Dr Golden and his publications.

A Safe, Effective Alternative to the Flu Vaccine

baby getting vaccinatedAbout a month and a half ago, I wrote about and gave evidence as to why the (swine) flu vaccine and treatment is not safe or effective. The mainstream media continues to hype the swine (H1N1) flu even though there have only been a total 79 deaths reported in Canada according to the Public Health Agency of Canada.

scienceThe current cover story in The Atlantic Magazine, “Does the Vaccine Matter?” goes over in detail the problems with the flu and swine flu vaccine, as well as the antiviral drugs used by doctors as standard treatment. They interview some experts who say that the flu and the swine flu vaccine are potentially useless. Some scientists reviewed the flu vaccine studies and found that they were biased by the “healthy user effect.” Healthy people are more likely to get the flu shot because they are more mobile, whereas the unhealthy people did not tend to get the flu shot. Most of the studies that have been published on the efficacy of the flu vaccine are flawed and riddled with bias. The cover story also talks about a few of the vocal, brave scientists who have spoken out against the flu vaccine, and have subsequently been snubbed and ignored by their peers and the scientific journals because they failed to tow the line.

Here’s the good news: there are alternatives that work. People with low immunity should get constitutional homeopathic treatment, it’s an absolute must for people with low immunity. There are also other natural ways to boost your immunity.

But, let’s say you have a strong immune system but still don’t want to risk getting the H1N1 or regular flu. Others are in high risk groups for the (swine) flu, such as pregnant women, the elderly, asthmatics, people with compromised immune systems, or young children. These people will all benefit from homeopathic flu immunizations.

To immunize against the flu, we use the homeopathic remedy Influenzinum. Influenzinum is a remedy made from flu viruses, rendered completely safe and non-toxic by a homeopathic pharmacist.

ist2_3805153-macro-of-homeopathic-pillsIn 1998 the French Society of Homeopathy conducted a survey of 23 homeopathic doctors concerning their use of Influenzinum as a flu preventative. The survey included use of Influenzinum over a 10 year period (1987-1998) in 458 patients. Results of the survey were remarkable. In approximately 90 percent of the cases no instances of the flu occurred when Influenzinum was used preventively.

I offer homeopathic immunizations for the flu at my clinic, and they are now available for purchase online. I use a high potency of Influenzinum 1M obtained from Helios Pharmacy in England. The immunization remedy must be taken once per month until the end of the flu season. It is taken by mouth and comes in the form of sugar pellets. It is safe and effective for pregnant women and children of any age, including babies.

Influenzinum-ThymulinePeople may have seen the Boiron product Influenzinum 9C in Canadian health food stores. Homeocan also carries Influenzinum. I have heard that the Homeocan and Boiron Influenzinum is not very effective because it is sourced from the regular influenza vaccine, whereas the Helios Influenzinum is sourced from actual influenza viruses. Plus the Boiron 9C is such a low potency that you would have to take it once a week for 6 months, which would be very time-consuming and costly.

However, there is another homeopathic immune-boosting product called Thymuline. I have heard that this product actually does boost the immune system so it might be worth a try.

Feel free to contact the clinic if you have any questions about homeopathic flu immunizations.

By Sonya McLeod
Google Plus Author Profile Page